covid
Buscar en
Endocrinología y Nutrición
Toda la web
Inicio Endocrinología y Nutrición Importancia de mantener una suficiente concentración sérica de T4 materna en e...
Información de la revista
Vol. 55. Núm. S1.
La erradicación de la deficiencia de yodo en españa
Páginas 54-60 (enero 2008)
Compartir
Compartir
Descargar PDF
Más opciones de artículo
Vol. 55. Núm. S1.
La erradicación de la deficiencia de yodo en españa
Páginas 54-60 (enero 2008)
La erradicación de la deficiencia de yodo en España
Acceso a texto completo
Importancia de mantener una suficiente concentración sérica de T4 materna en el primer trimestre del embarazo
Importance of ensuring sufficient maternal T4 levels in the first trimester of pregnancy
Visitas
3083
F. Morales García
Autor para correspondencia
currolhjsea@mixmail.com

Correspondencia: Dr. F. Morales García. Editor José Manuel Lara, 5, 2.° A. 41013 Sevilla. España.
, M.A. Martínez Brocca
Unidad de Gestión Clínica de Endocrinología y Nutrición. Hospital Universitario Virgen del Rocío. Sevilla. España
Este artículo ha recibido
Información del artículo
Resumen
Bibliografía
Descargar PDF
Estadísticas

El feto impone al sistema endocrino materno unas condiciones de gran valor para su propio desarrollo óptimo, y quedan temporalmente sobreseídos mecanismos endocrinos habituales. La transferencia maternofetal de T4 representa una contribución importante a la economía tiroidea fetal, necesaria para un buen desarrollo del sistema nervioso central del feto, desde comienzos del embarazo hasta el nacimiento, en especial en la primera mitad, antes de que aparezca una significativa función tiroidea fetal propia. A estos efectos, es imprescindible contar con la integridad de la capacidad funcional tiroidea y sus mecanismos de regulación y disponer de adecuados almacenes de yodo.

Estudios epidemiológicos y experimentales han puesto claramente en evidencia que la hipotiroxinemia materna en el primer trimestre de embarazo implica un incremento del riesgo para un pobre desarrollo neuropsicológico de los hijos.

Palabras clave:
Principio del embarazo
Deficiencia de yodo
Hipotiroxinemia materna
Neurodesarrollo fetal
Suplementación de yodo

The maternal endocrine system is essential for optimal fetal development, and normal endocrine mechanisms are temporarily supplanted during pregnancy. Transplacental transfer of thyroid hormone plays a crucial role in fetal neurodevelopment throughout ontogeny, especially before mid-gestation when fetal thyroid synthesis becomes significant. Thus, normal maternal thyroid hormone function is essential, ensuring adequate thyroid hormone and iodine levels throughout pregnancy. Epidemiological and experimental studies have robustly shown that maternal hypothyroxinemia in the first trimester of pregnancy increases the risk for adverse neurodevelopmental and neuropsychological outcomes in offspring.

Key words:
Early pregnancy
Iodine deficiency
Hypothyroxinemia
Fetal neurodevelopment
Iodine supplementation
El Texto completo está disponible en PDF
Bibliografía
[1.]
Delbert A. Fisher.
Fetal thyroid function: Diagnosis and management of fetal thyroid disorders.
Clin Obstet Gynecol, 40 (1997), pp. 16-31
[2.]
Ross DS. Euthyroid hyperthyroxinemia and hypothyroxinemia. Upto-Date 13.2.
[3.]
LaFranchi S. Thyroid physiology in the fetus and preterm and term infants. UptoDate 13.2.
[4.]
R.T. Zoeller.
Transplacental thyroxine and fetal brain development.
J Clin Invest, 111 (2003), pp. 954-957
[5.]
LaFranchi S. Clinical features and detection of congenital hypothyroidism. UptoDate. 13.2.
[6.]
D. Glinoer.
Maternal and fetal impact of chronic iodine deficiency.
Clin Obstet Gynecol, 40 (1997), pp. 102-116
[7.]
N. Ohara, T. Tsujino, T. Maruo.
The role of thyroid hormone in trophoblast function, early pregnancy maintenance, and fetal neurodevelopment.
J Obstet Gynaecol Can, 26 (2004), pp. 982-990
[8.]
F.M. Delange.
Endemic cretinism.
The thyroid. A fundamental and clinical text, pp. 731-744
[9.]
G. Morreale de Escobar.
Yodo y embarazo.
Yodo y salud en el siglo XXI, European Pharmaceutical Law Group, (2004),
[10.]
M.H.A. Kester, R. Martínez de Mena, M.J. Obregón, D. Marinkovic, A. Howatson, T.J. Visser.
Iodothyronine levels in the human developing brain: major regulatory roles of iodothyronine deiodinases in different areas.
J Clin Endocrinol Metab, 89 (2004), pp. 3117-3128
[11.]
R. Lavado-Autric, E. Ausó, J.V. García Velasco, C. Arufe, F. Escobar del Rey, P. Barbel, et al.
Early maternal hypothyroxinemia alters histogenesis and cerebral cortex cytoarchitecture of the progeny.
Clin Invest, 111 (2003), pp. 1073-1082
[12.]
Ross DS. Overview of thyroid disease in pregnancy. UptoDate 13.2.
[13.]
G.A. Brent.
Maternal thyroid function: interpretation of thyroid function tests in pregnancy.
Clin Obstet Gynecol, 40 (1997), pp. 3-15
[14.]
J.H. Lazarus, L.D. Premawardhama.
Screening for thyroid disease in pregnancy.
Best Pract, (2004),
[15.]
D. Glinoer.
Feto-maternal repercussions of iodine deficiency during pregnancy. An update.
Ann Endocrinol (Paris), 64 (2003), pp. 37-44
[16.]
M.S. Shah, T.F. Davies, A. Stagnaro Green.
The thyroid during pregnancy: a physiological and pathological stress test.
Minerva Endocrinol, 28 (2003), pp. 233-245
[17.]
R.C. Smallridge, D. Glinoer, J.G. Hollowell, G. Brent.
Thyroid function inside and outside of pregnancy: what do we know and what don’t we know?.
Thyroid, 15 (2005), pp. 54-59
[18.]
V.J. Pop, T. Vulsma.
Maternal hypothyroxinemia during (early) gestation.
Lancet, 365 (2005), pp. 1604-1606
[19.]
F.L.R. Williams, S.A. Ogston, H. Van Toor, T.J. Visser, R. Hume.
Serum thyroid hormones in preterm infants: associations with postnatal illnesses and drug usage.
J Clin Endocrinol Metab, 90 (2005), pp. 5954-5963
[20.]
LaFranchi S. Treatment and prognosis of congenital hypothyroidism. UptoDate 13.2.
[21.]
G. Morreale de Escobar.
Is neuropsychological development related to maternal hypothyroidism or to maternal hypothyroxinemia?.
J Clin Endocrinol Metab, 85 (2000), pp. 3975-3987
[22.]
F. Vermiglio, V.P. Lo Presti, M. Moleti, M. Sidoti, G. Tortorella, G. Scaffidi, et al.
Attention deficit and hyperactivity disorders in the offspring of mothers exposed to mild-moderate iodine deficiency: a possible novel iodine deficiency disorder in developed countries.
J Clin Endocrinol Metab, 89 (2004), pp. 6054-6060
[23.]
L. Kooistra, S. Crowford, L. Van Baar, E.P. Brouwers, V.J. Pop.
Neonatal effects of maternal hypothyroxinemia during early pregnancy.
Pediatrics, 117 (2006), pp. 161-167
[24.]
F. Vermiglio.
Maternal hypothyroixnemia during the first half of gestation in an iodine deficient area with endemic cretinism and related disorders.
Clin Endocrinol (Oxf), 42 (1995), pp. 409-415
[25.]
E. Auso, R. Lavado, E. Cuevas, F.E. Del Rey, G. Morreale de Escobar, P. Berbel.
A moderate and transient deficiency of maternal thyroid function at the beginning of fetal neocorticogenesis alters neuronal migration.
Endocrinology, 145 (2004), pp. 4037-4047
[26.]
D. Glinoer.
Thyroid disease during pregnancy.
The thyroid. A fundamental and clinical text, pp. 1086-1108
[27.]
J.H. Lazarus.
Epidemiology and prevention of thyroid disease in pregnancy.
Thyroid, 12 (2002), pp. 861-865
[28.]
V.J. Pop, E.P. Brouwers, H.L. Vader, T. Vulsma, A.L. Van Baar, J.J. De Vijlder.
Maternal hypothyroxinaemia during early pregnancy and subsequent child development: a 3-year follow-up study.
Clin Endocrinol (Oxf), 59 (2003), pp. 280-281
[29.]
M.I. Surks, E. Ortiz, G.H. Daniels, C.T. Samin, N.F. Col, R.H. Cobin, et al.
Subclinical thyroid disease. Scientific review and guidelines for diagnosis and management.
JAMA, 291 (2004), pp. 228-238
[30.]
S.H. LaFranchi, J.E. Haddow, J.G. Hollowell.
Is thyroid inadequacy during gestation a risk factor for adverse pregnancy and developmental outcomes?.
Thyroid, 15 (2005), pp. 60-71
[31.]
E. Fliers, W.M. Wiersinga.
Screening pregnant women for hypothyroidism: as yet only in high risk groups.
Ned Tijdschr Geneeskd, 147 (2003), pp. 1159-1161
[32.]
J.H. Lazarus.
Thyroid disorders associated with pregnancy: etiology, diagnosis, and management.
Treat Endocrinol, 4 (2005), pp. 31-41
[33.]
G. Morreale de Escobar, F. Escobar del Rey, M.J. Obregón.
Maternal hypothyroxinemia and neurodevelopment: to screen or not to screen; to treat or not to treat.
Hot Thyroidology, (2002),
Copyright © 2008. Sociedad Española de Endocrinología y Nutrición
Opciones de artículo
es en pt

¿Es usted profesional sanitario apto para prescribir o dispensar medicamentos?

Are you a health professional able to prescribe or dispense drugs?

Você é um profissional de saúde habilitado a prescrever ou dispensar medicamentos